Roble Belko & Company Inc increased its stake in iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report) by 44.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,247 shares of the company’s stock after acquiring an additional 3,134 shares during the quarter. Roble Belko & Company Inc’s holdings in iShares iBonds Dec 2032 Term Corporate ETF were worth $259,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in IBDX. NewEdge Advisors LLC lifted its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 375.3% in the first quarter. NewEdge Advisors LLC now owns 167,816 shares of the company’s stock worth $4,194,000 after acquiring an additional 132,506 shares during the period. Lbmc Investment Advisors LLC acquired a new position in shares of iShares iBonds Dec 2032 Term Corporate ETF in the second quarter worth approximately $1,100,000. Janney Montgomery Scott LLC lifted its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 6.3% in the second quarter. Janney Montgomery Scott LLC now owns 317,816 shares of the company’s stock worth $8,036,000 after acquiring an additional 18,910 shares during the period. Parallel Advisors LLC lifted its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 8.7% in the second quarter. Parallel Advisors LLC now owns 218,176 shares of the company’s stock worth $5,517,000 after acquiring an additional 17,384 shares during the period. Finally, Belpointe Asset Management LLC acquired a new position in shares of iShares iBonds Dec 2032 Term Corporate ETF in the second quarter worth approximately $420,000.
iShares iBonds Dec 2032 Term Corporate ETF Stock Down 0.1%
iShares iBonds Dec 2032 Term Corporate ETF stock opened at $25.59 on Friday. The stock’s 50 day moving average is $25.63 and its 200 day moving average is $25.22. iShares iBonds Dec 2032 Term Corporate ETF has a one year low of $24.05 and a one year high of $26.77.
About iShares iBonds Dec 2032 Term Corporate ETF
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- Quiet Period Expirations Explained
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- How is Compound Interest Calculated?
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- Top Stocks Investing in 5G Technology
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
